Business Context and Reporting Period
This Form 8-K is filed by OncoGenex Pharmaceuticals, Inc. (noted as "ACHIEVE LIFE SCIENCES, INC." in metadata, but identified as OncoGenex in the filing text) on May 6, 2010. The report discloses the issuance of a press release regarding financial results for the quarter ended March 31, 2010.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not reproduced in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves solely as a notification that the Company has announced its quarterly results.
Guidance, Outlook, and Risks
The text does not contain management commentary, guidance, outlook, or specific risk factors. It explicitly states that the attached press release is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the press release dated May 6, 2010).
- Confirm the discrepancy between the metadata company name ("ACHIEVE LIFE SCIENCES, INC.") and the registrant name in the filing ("ONCOGENEX PHARMACEUTICALS, INC.").
- Review the full press release for any forward-looking statements or clinical trial updates not summarized in this 8-K.